Company Filing History:
Years Active: 2000-2005
Title: **Michael Shin-San Su: Innovator in Biomedical Research**
Introduction
Michael Shin-San Su is a prominent inventor based in Newton, Massachusetts. With a total of three patents to his name, Su is making significant strides in the fields of molecular biology and drug development. His innovative work primarily focuses on designing inhibitors for various kinases, which play critical roles in numerous cellular processes.
Latest Patents
Su's latest patents include groundbreaking methodologies and compounds with potential therapeutic applications. One of his notable inventions is related to "Methods for designing inhibitors of serine/threonine kinases and tyrosine kinases". This invention emphasizes the use of ATP-binding site mutants of kinases, particularly MAP kinases. By binding more efficiently to inhibitory compounds than their wild-type counterparts, these mutant kinases hold promise for targeted treatments in oncology and other fields.
Another significant patent focuses on "Butyrate prodrugs derived from lactic acid", presenting a novel approach for treating inflammatory bowel disease. This invention also extends to managing chemotherapy-induced mucocutaneous side effects and offers potential therapeutic avenues for various cancers, including lung, colorectal, and prostate cancer. Furthermore, it explores applications for cystic fibrosis and enhances gene therapy efficiency, showcasing a versatile approach to drug formulation.
Career Highlights
Michael Shin-San Su currently contributes his expertise at Vertex Pharmaceuticals, Inc. His role in this leading biopharmaceutical company allows him to collaborate with top professionals in the industry and advance innovative treatments that could significantly impact patient care. His contributions are vital in addressing critical health challenges through scientific research and invention.
Collaborations
Throughout his career, Su has collaborated with esteemed colleagues such as Ted Fox and Keith P. Wilson. These partnerships not only enrich his work but also promote a collaborative atmosphere in research and development, leading to improved methodologies and impactful inventions. His interactions with other professionals in the field have undoubtedly enhanced the quality and scope of his projects.
Conclusion
In summary, Michael Shin-San Su stands out as a dedicated inventor whose work is driven by a passion for innovation in the biomedical sector. With multiple patents highlighting his contributions to drug development and treatment methodologies, he continues to be a significant figure in the scientific community. At Vertex Pharmaceuticals, Inc., Su is well-positioned to further his research and create lasting impacts on healthcare and patient outcomes.